
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
1 Department of Molecular and Surgical Oncology, Medical Institute of Bioregulation, Kyushu University, Beppu, Japan; and 2 Department of Surgery, Saitama Prefectural Cancer Center, Saitama, Japan
ABSTRACT
Purpose: Activin A is a member of the transforming growth factor ß superfamily and plays an important role in the differentiation of embryonic stem cells. We have reported previously that the expression of activin A is associated with lymph node metastasis in esophageal cancer, and our purpose in the current work is to clarify the molecular mechanism of the aggressive behavior of tumors that have high activin A expression.
Experimental Design: We have compared the gene expression profiles of human esophageal carcinoma cell lines that were stably transfected with activin ßA, which is a subunit of activin A, with those of control human esophageal carcinoma cell lines, using a cDNA microarray.
Results: We found that the expression level of neuronal cadherin (N-cadherin) was higher in the transfectants than in the control cells. N-cadherin was located on the cell surface of the transfectants, irrespective of the expression of epithelial cadherin (E-cadherin), and the expression of N-cadherin mRNA was significantly associated with that of activin ßA mRNA in clinical samples of esophageal carcinoma (n = 51; r = 0.855). A clinicopathologic analysis suggested that expression of N-cadherin mRNA was associated with the depth of tumor wall invasion, and a group of patients with high expression of N-cadherin mRNA showed a significantly poorer prognosis than a group of patients with low N-cadherin expression (P = 0.046).
Conclusions: These results indicate that activin A might mediate the expression of N-cadherin and that this may be associated with depth of invasion and poor prognosis.
This article has been cited by other articles:
![]() |
M.C. Ferreira, C.A. Witz, L.S. Hammes, N. Kirma, F. Petraglia, R.S. Schenken, and F.M. Reis Activin A increases invasiveness of endometrial cells in an in vitro model of human peritoneum Mol. Hum. Reprod., May 1, 2008; 14(5): 301 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yoshinaga, K. Yamashita, K. Mimori, F. Tanaka, H. Inoue, and M. Mori Activin A Causes Cancer Cell Aggressiveness in Esophageal Squamous Cell Carcinoma Cells Ann. Surg. Oncol., January 1, 2008; 15(1): 96 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-G. Chen, Q. Wang, S.-L. Lin, C. D. Chang, J. Chung, and S.-Y. Ying Activin Signaling and Its Role in Regulation of Cell Proliferation, Apoptosis, and Carcinogenesis. Experimental Biology and Medicine, May 1, 2006; 231(5): 534 - 544. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |